![](https://martechmetrix.com/assets/news_images/34741_0_jnj_logo_singleline_red_rgb.jpg)
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held at the New York Marriott Marquis, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice President, Innovative Medicine, R&D will represent the Company in a session scheduled at 10:45 am (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/